Inventor · disambiguated record
Alison Hannah
Also filed as: HANNAH ALISON · HANNAH ALISON L · HANNAH ALISON LENNOX
3 granted patents·5 pending applications·8 citations·filing 2002–2018
59Inventor score
Files withJOHNSON ROBERT G JR2NEKTAR THERAPEUTICS2KOSAN BIOSCIENCES INC1KOSAN BIOSCIENCES INC A DELAWA1NOVARTIS VACCINES & DIAGNOSTIC1
Top patents by PatentIndex Score
8 records- 0174US10132810B2Method for assessing and predicting efficacy of breast cancer treatment with a long-acting topoisomerase I inhibitorNEKTAR THERAPEUTICS·Filed 2013·Granted Nov 20, 2018·3 cites·17 claims
- 0267US7838527B2Methods of treating cancer and related methodsNOVARTIS VACCINES & DIAGNOSTIC·Filed 2003·Granted Nov 23, 2010·5 cites·47 claims
- 0356US2019049450A1Method for Assessing and Predicting Efficacy of Breast Cancer Treatment with a Long-Acting Topoisomerase I InhibitorNEKTAR THERAPEUTICS·Filed 2018·Application pending·0 cites
- 0436US7691392B2Method of treating multiple myeloma using 17-AAG or 17-AG or a prodrug of eitherKOSAN BIOSCIENCES INC·Filed 2006·Granted Apr 6, 2010·0 cites·38 claims
- 0536US2003191162A13-heteroarylidenyl-2-indolinone compounds for modulating protein kinase activity and for use in cancer chemotherapySUGEN INC·Filed 2002·Application pending·0 cites
- 0636US2004072882A1Methods to administer epothilone DKOSAN BIOSCIENCES INC A DELAWA·Filed 2003·Application pending·0 cites
- 0732US2009197852A9Method of treating breast cancer using 17-AAG or 17-AG or a prodrug of either in combination with a HER2 inhibitorJOHNSON ROBERT G JR·Filed 2006·Application pending·0 cites
- 0831US2006252740A1Method of treating multiple myeloma using 17-AAG or 17-AG or a prodrug of either in combination with a proteasome inhibitorJOHNSON ROBERT G JR·Filed 2006·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →